ArticleLeukemia2017

Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.

A Etxabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.